GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » EPS (Basic)

NKY Medical Holdings (SZSE:300109) EPS (Basic) : ¥1.58 (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings EPS (Basic)?

NKY Medical Holdings's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.38. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.58.

NKY Medical Holdings's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.38. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.53.

NKY Medical Holdings's EPS without NRI for the three months ended in Mar. 2024 was ¥0.41. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 1.57.

During the past 12 months, NKY Medical Holdings's average EPS without NRIGrowth Rate was 27.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 165.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 25.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, NKY Medical Holdings's highest 3-Year average EPS without NRI Growth Rate was 165.70% per year. The lowest was -57.80% per year. And the median was 7.55% per year.


NKY Medical Holdings EPS (Basic) Historical Data

The historical data trend for NKY Medical Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings EPS (Basic) Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 0.14 0.64 0.88 1.59

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.44 0.45 0.31 0.38

NKY Medical Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

NKY Medical Holdings's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(493.027-0)/310.080
=1.59

NKY Medical Holdings's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(121.387-0)/319.441
=0.38

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKY Medical Holdings  (SZSE:300109) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


NKY Medical Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.
Executives
Zhang Jun Zheng Directors, executives
Yang Hong Bo Director
Wang Dong Hu Director
Ren Da Long Director
Xing Xiao Liang Directors, executives
Zou Xiao Wen Executives
Wang Shi Gang Executives
Wang Xin Meng Executives
Qu Yun Xia Supervisors
Wang Jian Qiang Director
Yang Hai Jiang Director
Yan Zhong Chao Supervisors
Liu Ai Min Executives
Wu Cong Zhou Executives
Wu Wen Bin Director

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines